Transcription
Gaurav Manchanda 0:05
My name is Gaurav Manchanda with Formlabs though we're a sponsor, and I'm the session leader for track the next track here or for track three, but the next session, I'll introduce the speakers in just a moment. But as a sponsor honor to take just a few minutes to introduce Formlabs and what we're doing in the healthcare space. So quick disclaimer. So Formlabs, we are roughly a 10 year old company, we came out of the MIT Media Lab back in 2011 2012. Our focus was on making professional grade 3d printers accessible and affordable our machines are roughly 1/10 of the cost of the competition. And as a result, we've become the market leader over the last 10 years, over 100,000 machines sold across a variety of industries, including roughly 30,000 in the healthcare space. Those machines have been used by a range of stakeholders, which I mentioned on a future slide to produce a range of instruments supporting many surgeries and many, many medical devices being produced, including roughly 70 million NP swabs during the pandemic. That's what we're today we're growing quickly and stronger than ever, over 200 distributors deploying our products worldwide. In 150 employees or so HQ in Cambridge, Mass soft bank led our Series A in 2021, which got us to the $2 billion dollar valuation mark and offices globally as well. So in terms of the markets that we serve within the medical space, you'll see a wide range of sectors here and these stakeholders are producing patients, patient match tools, mass produced devices and a range of manufacturing aids as well. You'll see med tech OEMs in the left hand side a wide range of industries there but primary focus or their primary focus is tend to be in the surgery space and o NP. We also have biotech life sciences and pharma, as well as medical education and research. And I'm mentioning point of care manufacturers or hospital based manufacturers. Last as those are newer entrants to the medical device manufacturing space, but primarily using CT or MRI to produce patient matched surgical devices, as well as radiation oncology devices as well. So we have become the market leader in in professional graded printing. Thanks to the affordability, the ease of use, and some automation tools that have come out fairly recently, I can see a few of our hero parts here as well as many more on our table outside. And I'm sorry, the screen up cut out over here. But what we do have to offer in addition to our hardware, our materials and our software is a very strong foundation in the quality and regulatory arena. So we do manufacture our medical grade materials and a 1345 FDA registered facility where we do a wide range of biocompatibility testing, to give our customers confidence that these materials will meet their needs. And we've our our QA team has supported a number of customers in receiving their own 510 ks for their respective end use devices. So with the remaining time it does have two or three case studies. What these are available on our parts are seen on our table outside but one is Psyonic. This is a San Diego based startup, which does have a commercially available Medicare covered prosthetic hand. This is the most advanced hand on the market and fully covered by Medicare. We're at restore 3d This is roughly 100 person company in the North Carolina Research Triangle. They're directly printing single use trials and inserters that are replacing devices often found in larger expensive surgical trays and instruments. This is leading to cost reductions across the board. And last class case study here is from Mayo Clinic one of those point of care manufacturers I mentioned which is using patient imaging to produce cutting guides for mandibular free flaps for example, cutting guides and fixation trays for implant sizing and this is saving them over 1000 hours in the OR a year and all of the associated benefits of blood loss anesthesia etc. So with that, I will introduce our speakers and feel free to please do feel free to visit us right outside where the first table on the right hand, right hand side after the exit
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
